{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:57:25Z","timestamp":1761580645796},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1007\/bf02988618","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T12:13:20Z","timestamp":1227701600000},"page":"337-345","source":"Crossref","is-referenced-by-count":68,"title":["Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Masayuki","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichirou","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02988618_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1148\/radiology.175.2.2183289","volume":"175","author":"D Front","year":"1990","unstructured":"Front D, Israel O, Epelbaum R, Ben Haim S, Even Sapir E, Jerushalmi J, et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990; 175: 515\u2013519.","journal-title":"Radiology"},{"key":"BF02988618_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s002590050024","volume":"27","author":"C Delcambre","year":"2000","unstructured":"Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, et al. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy. Eur J Nucl Med 2000; 27: 176\u2013184.","journal-title":"Eur J Nucl Med"},{"key":"BF02988618_CR3","first-page":"686","volume":"32","author":"J Okada","year":"1991","unstructured":"Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991; 32: 686\u2013691.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.190.1.8259386","volume":"190","author":"JS Newman","year":"1994","unstructured":"Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[18F]fluoro-2-deoxy-d-glucose: correlation with CT. Radiology 1994; 190: 111\u2013116.","journal-title":"Radiology"},{"key":"BF02988618_CR5","first-page":"343","volume":"38","author":"CK Hoh","year":"1997","unstructured":"Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997; 38: 343\u2013348.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.203.3.9169707","volume":"203","author":"F Moog","year":"1997","unstructured":"Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, et al. Lymphoma: Role of whole-body 2-deoxy-2-[18F]fluoro-d-glucose (FDG) PET in nodal staging. Radiology 1997; 203: 795\u2013800.","journal-title":"Radiology"},{"key":"BF02988618_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s002590050275","volume":"25","author":"KD Stumpe","year":"1998","unstructured":"Stumpe KD, Urbinelli M, Steinert HC, Glanzmann CH, Buck A, von Schulthness GK. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: Effectiveness and comparison with computed tomography. Eur J Nucl Med 1998; 25: 721\u2013728.","journal-title":"Eur J Nucl Med"},{"key":"BF02988618_CR8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1023\/A:1008486928190","volume":"9","author":"M Bangerter","year":"1998","unstructured":"Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, et al. Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 1998; 9: 1117\u20131122.","journal-title":"Ann Oncol"},{"key":"BF02988618_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00006231-199901000-00004","volume":"20","author":"G Jerusalem","year":"1999","unstructured":"Jerusalem G, Warland V, Najjar F, Paulus P, Fassotte MF, Fillet G, et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun 1999; 20: 13\u201320.","journal-title":"Nucl Med Commun"},{"key":"BF02988618_CR10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","volume":"12","author":"G Jerusalem","year":"2001","unstructured":"Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001; 12: 825\u2013830.","journal-title":"Ann Oncol"},{"key":"BF02988618_CR11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","volume":"91","author":"I Buchmann","year":"2001","unstructured":"Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al. 2-(fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001; 91: 889\u2013899.","journal-title":"Cancer"},{"key":"BF02988618_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1259\/bjr.73.869.10884743","volume":"73","author":"N Shah","year":"2000","unstructured":"Shah N, Hoskin P, McMillan A, Gibson P, Lowe J, Wong WL. The impact of FDG positron emission tomography imaging on the management of lymphomas. Br J Radiol 2000; 73: 482\u2013487.","journal-title":"Br J Radiol"},{"key":"BF02988618_CR13","first-page":"1139","volume":"42","author":"H Sch\u00f6der","year":"2001","unstructured":"Sch\u00f6der H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, et al. Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42: 1139\u20131143.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR14","first-page":"4464","volume":"91","author":"R\u00f6mer","year":"1998","unstructured":"R\u00f6mer, Hanauske AR, Ziegler S, Th\u00f6dtmann R, Weber W, Fuchs C, et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 1998; 91: 4464\u20134471.","journal-title":"Blood"},{"key":"BF02988618_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/10428190009113384","volume":"39","author":"NG Mikhaeel","year":"2000","unstructured":"Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma\u2014comparison with CT. Leukemia and Lymphoma 2000; 39: 5\u20136.","journal-title":"Leukemia and Lymphoma"},{"key":"BF02988618_CR16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001; 19: 414\u2013419.","journal-title":"J Clin Oncol"},{"key":"BF02988618_CR17","first-page":"288","volume":"28","author":"R Paul","year":"1987","unstructured":"Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 1987; 28: 288\u2013292.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(83)91212-3","volume":"75","author":"KC Anderson","year":"1983","unstructured":"Anderson KC, Leonard RC, Canellos GP, Skarin AT, Kaplan WD. High-dose gallium imaging in lymphoma. Am J Med 1983; 75: 327\u2013331.","journal-title":"Am J Med"},{"key":"BF02988618_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.164.1.3495815","volume":"164","author":"SS Tumeh","year":"1987","unstructured":"Tumeh SS, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT. Radiology 1987; 164: 111\u2013114.","journal-title":"Radiology"},{"key":"BF02988618_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3816\/CLM.2000.n.007","volume":"1","author":"L Kostakoglu","year":"2000","unstructured":"Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: comparison with computed tomography and gallium-67 single photon emission computed tomography. Clin Lymphoma 2000; 1: 67\u201374.","journal-title":"Clin Lymphoma"},{"key":"BF02988618_CR21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/radiology.206.2.9457202","volume":"206","author":"F Moog","year":"1998","unstructured":"Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 1998; 206: 475\u2013481.","journal-title":"Radiology"},{"key":"BF02988618_CR22","first-page":"486","volume":"14","author":"M Sasaki","year":"1990","unstructured":"Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, et al. Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990; 14: 486\u2013487.","journal-title":"J Comput Assist Tomogr"},{"key":"BF02988618_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03165391","volume":"10","author":"Y Ichiya","year":"1996","unstructured":"Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185\u2013191.","journal-title":"Ann Nucl Med"},{"key":"BF02988618_CR24","first-page":"601","volume":"42","author":"M Tatsumi","year":"2001","unstructured":"Tatsumi M, Kitayama H, Sugahara H, Tokita N, Nakamura H, Kanakura Y, et al. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med 2001; 42: 601\u2013608.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR25","first-page":"325","volume":"33","author":"J Okada","year":"1992","unstructured":"Okada J, Yoshikawa K, Itami M, Imazeki K, Uno K, Itami J, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity. J Nucl Med 1992; 33: 325\u2013329.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR26","first-page":"1790","volume":"36","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Rehn S, Ahlstr\u00f6m H, Sundstr\u00f6m C, Glimelius B. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J Nucl Med 1995; 36: 1790\u20131796.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR27","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood.V86.9.3522.bloodjournal8693522","volume":"86","author":"M Lapela","year":"1995","unstructured":"Lapela M, Leskinen S, Minn HRI, Lindholm P, Klemi PJ, S\u00f6derstr\u00f6m KO, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995; 86: 3522\u20133527.","journal-title":"Blood"},{"key":"BF02988618_CR28","first-page":"1211","volume":"32","author":"S Leskinen-Kallio","year":"1991","unstructured":"Leskinen-Kallio S, Ruotsalainen U, N\u00e5gren K, Ter\u00e4s M, Joensuu H. Uptake of carbon-11 methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study. J Nucl Med 1991; 32: 1211\u20131218.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1008312726163","volume":"10","author":"M Hoffmann","year":"1999","unstructured":"Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999; 10: 1185\u20131189.","journal-title":"Ann Oncol"},{"key":"BF02988618_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/02841869709001319","volume":"36","author":"M Rodriguez","year":"1997","unstructured":"Rodriguez M, Ahlstr\u00f6m H, Sund\u00edn A, Rehn S, Sundstr\u00f6m C, Hagberg H, et al. [18F]FDG PET in gastric non-Hodgkin's lymphoma. Acta Oncologica 1997; 36: 577\u2013584.","journal-title":"Acta Oncologica"},{"key":"BF02988618_CR31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00837630","volume":"23","author":"F Gr\u00fcnwald","year":"1996","unstructured":"Gr\u00fcnwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996; 23: 312\u2013319.","journal-title":"Eur J Nucl Med"},{"key":"BF02988618_CR32","first-page":"990","volume":"38","author":"SP Bartold","year":"1997","unstructured":"Bartold SP, Donohoe KJ, Fletcher JW, Haynie TP, Henkin RE, Silberstein EB, et al. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. J Nucl Med 1997; 38: 990\u2013994.","journal-title":"J Nucl Med"},{"key":"BF02988618_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002590050356","volume":"26","author":"J Kotzerke","year":"1999","unstructured":"Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26: 31\u201338.","journal-title":"Eur J Nucl Med"},{"key":"BF02988618_CR34","first-page":"1091","volume":"24","author":"FM Bengel","year":"1997","unstructured":"Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24: 1091\u20131098.","journal-title":"Eur J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02988618\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:44:18Z","timestamp":1589190258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02988618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["BF02988618"],"URL":"https:\/\/doi.org\/10.1007\/bf02988618","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}